Trial NCT03922477

View at ClinicalTrials.gov 
Org. Study IDs: GO40828

Last trial update was posted on 2022-02-21

MeSH Interventions

Atezolizumab Magrolimab

MeSH Conditions

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute

Other Conditions

Acute Myeloid Leukemia

Stopping Reasons

The Sponsor decided to discontinue the development of atezolizumab in combination with magrolimab in the AML indication.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID